Job openings on the Paratek Pharmaceuticals team are listed below along with a downloadable description of each position. Click the job title to learn more about the position. Apply for a position at Paratek Pharmaceuticals today >>
Paratek Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon its expertise in novel tetracycline chemistry.
Paratek's lead candidate, omadacycline, is an aminomethylcycline, a semisynthetic derivative related to the tetracycline class of antibiotics.
The Food and Drug Administration (FDA) granted omadacycline a Qualified Infectious Disease Product (QIDP) designation and completed two special protocol assessments for its Phase 3 clinical trial program.
Our second Phase 3 product candidate, sarecycline, is an oral tetracycline-derived compound. Paratek has licensed the U.S. rights to Allergan for the development and commercialization of sarecycline. Paratek retains all ex-U.S. rights.